This site is intended for UK healthcare professionals only
Prostate Cancer UK’s top priority is funding research to stop prostate cancer killing men. We’re investing millions to find better treatments and better tests that can spot fast-growing cancers early, and could be used in a screening programme to save thousands of lives.
We were the first national organisation for prostate cancer in the UK. Our aim was to improve the care and welfare of those affected by prostate cancer, increase investment in research, and raise public and political awareness of a long-neglected disease. In the last 20 years, we’ve invested over £37 million into ground breaking research, and continue to provide award-winning support for men.
We have grown in size, strength and influence but our ambition is the same: to put men at the heart of everything we do.
Resources
Counselling Patients on the PSA Blood Test – Pros and Cons
This resource has been developed, organised and funded by Boehringer Ingelheim. The content has been reviewed and approved by the sponsoring company prior to the symposium. Editorial support for this symposium has been provided by OmniaMed Communications.
